Relation of elevated plasma renin activity at baseline to cardiac events in patients with angiographically proven coronary artery disease

American Journal of Cardiology

Volumn 106, Issue 6, 2010, Pages 764-769

  Muhlestein, Joseph B ^a,b   May, Heidi T ^a   Bair, Tami L ^a   Prescott, Margaret F ^c   Horne, Benjamin D ^a,b   White, Richard ^d   Anderson, Jeffrey L ^a,b  

^a INTERMOUNTAIN MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

^d OXFORD PHARMAGENESIS LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; BIOLOGICAL MARKER; RENIN;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SMOKING; ANGIOCARDIOGRAPHY; BLOOD; COMPLICATION; LENGTH OF STAY; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RADIOGRAPHY; REGRESSION ANALYSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SURVIVAL;

AGED; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; HYPERTENSION; LENGTH OF STAY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RENIN; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 77956343748     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.04.040     Document Type: Article

References (14)

1. H.R. Brunner, J.H. Laragh, L. Baer, M.A. Newton, F.T. Goodwin, L.R. Krakoff, R.H. Bard, and F.R. Buhler Essential hypertension: renin and aldosterone, heart attack and stroke N Engl J Med 286 1972 441 449
2. J.D. Blumenfeld, J.E. Sealey, M.H. Alderman, H. Cohen, R. Lappin, D.F. Catanzaro, and J.H. Laragh Plasma renin activity in the emergency department and its independent association with acute myocardial infarction Am J Hypertens 13 2000 855 863
3. M.H. Alderman, W.L. Ooi, H. Cohen, S. Madhavan, J.E. Sealey, and J.H. Laragh Plasma renin activity: a risk factor for myocardial infarction in hypertensive patients Am J Hypertens 10 1997 1 8
4. R. Latini, S. Masson, I. Anand, M. Salio, A. Hester, D. Judd, S. Barlera, A.P. Maggioni, G. Tognoni, and J.N. Cohn The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT Eur Heart J 25 2004 292 299
5. G. Vergaro, M. Fontana, R. Poletti, A. Giannoni, A.L. Iervasi, L. Masi, C. Mammini, A. Gabutti, C. Passino, and M. Emdin Plasma renin activity is an independent prognostic factor in chronic heart failure (abstract) Eur Heart J 29 Suppl 1 2008 393
6. J.L. Rouleau, M. Packer, L. Moye, J. de Champlain, D. Bichet, M. Klein, J.R. Rouleau, B. Sussex, J.M. Arnold, and F. Sestier Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril J Am Coll Cardiol 24 1994 583 591
7. S. Verma, M. Gupta, D.T. Holmes, H. Teoh, L. Xu, S. Yusuf, and E.M. Lonn Plasma renin activity is associated with increased cardiovascular events and mortality in the HOPE study (abstract) Circulation 120 2009 S453
8. J.W. Fung, C.M. Yu, G. Yip, S. Chan, T.G. Yandle, A.M. Richards, M.G. Nicholls, and J.E. Sanderson Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure Am J Cardiol 92 2003 406 410
9. P.S. Sever, A.H. Gradman, and M. Azizi Managing cardiovascular and renal risk: the potential of direct renin inhibition J Renin Angiotensin Aldosterone Syst 10 2009 65 76
10. H.H. Parving, B.M. Brenner, J.J. McMurray, D. de Zeeuw, S.M. Haffner, S.D. Solomon, N. Chaturvedi, M. Ghadanfar, N. Weissbach, Z. Xiang, J. Armbrecht, and M.A. Pfeffer Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design Nephrol Dial Transplant 24 2009 1663 1671
11. B.S. Ronnow, S.P. Reyna, J.B. Muhlestein, B.D. Horne, C.A. Allen Maycock, T.L. Bair, J.F. Carlquist, A.G. Kfoury, J.L. Anderson, and D.G. Renlund C-reactive protein predicts death in patients with non-ischemic cardiomyopathy Cardiology 104 2005 196 201
12. M. Azizi, and J. Menard Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists Circulation 109 2004 2492 2499
13. P. Lijnen, R. Fagard, J. Staessen, and A. Amery Effect of chronic diuretic treatment on the plasma renin-angiotensin-aldosterone system in essential hypertension Br J Clin Pharmacol 12 1981 387 392
14. D. Colantonio, R. Casale, P. Desiati, G. Giandomenico, V. Bucci, and P. Pasqualetti Short-term effects of atenolol and nifedipine on atrial natriuretic peptide, plasma renin activity, and plasma aldosterone in patients with essential hypertension J Clin Pharmacol 31 1991 238 242